NR3C1 and prostate cancer: Representative IHC images of 4 selected patients from the GR+ group (patient 59 and 32) and the GR− group (patient 43 and 60) demonstrated presence of GR expression in prostate cancer tumor cells, whereas lower GR expression was observed in the patients from the GR− group (Fig. 6E).